TNF and Hypertension: At the time of data collection, the number (%) of participants undertaking different pharmaceutical treatments were as follows; Disease Modifying Anti-Rheumatic Drugs (DMARDS, 53%), anti-TNF therapy (10%), Non-Steroidal Anti-Inflammatory Drugs (NSAIDs, 36%), analgesics (33%), cholesterol lowering medication (23%), medication for hypertension (20%).